Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÇÁ·Î½ºÅ¸±Û¶õµò Á¦Á¦ÀÇ Àå±â Á¡¾ÈÀÌ Á߽ɰ¢¸·µÎ²²¿Í ¾È¾Ð¿¡ ¹ÌÄ¡´Â ¿µÇâ The Long-term Effects of Prostaglandin Analogues on Central Corneal Thickness and Intraocular Pressure

´ëÇѾȰúÇÐȸÁö 2020³â 61±Ç 6È£ p.650 ~ 657
¼ÛÁöÀº, À̹̿¬, Á¤ÇÊ¿í, ±èÁظð,
¼Ò¼Ó »ó¼¼Á¤º¸
¼ÛÁöÀº ( Song Ji-Eun ) 
Sungkyunkwan University School of Medicine Kangbuk Samsung Hospital Department of Ophthalmology

À̹̿¬ ( Lee Mi-Yeon ) 
Kangbuk Samsung Hospital Department of Medical Information
Á¤ÇÊ¿í ( Chung Pil-Wook ) 
Sungkyunkwan University School of Medicine Kangbuk Samsung Hospital Department of Neurology
±èÁظð ( Kim Joon-Mo ) 
Sungkyunkwan University School of Medicine Kangbuk Samsung Hospital Department of Ophthalmology

Abstract


Purpose: To evaluate the long-term effect of 0.005% latanoprost (LA) and 0.0015% tafluprost (TA) on intraocular pressure (IOP) and central corneal thickness (CCT) in glaucoma patients.

Methods: This study was a retrospective study, which enrolled open-angle glaucoma (OAG) patients treated with one of two prostaglandin analogues. The patients were observed for at least three years and underwent corneal thickness measurements at least once a year. Patients with a history of ocular surgery except cataract surgery or another glaucoma medication during the follow-up were excluded. Goldmann applanation tonometry and specular microscopy were used to measure the IOP and CCT, respectively. Changes in IOP and CCT were compared between the two groups.

Results: A total of 55 OAG patients (110 eyes) were enrolled. The patients were divided into two groups; one group (50 eyes) used LA as anti-glaucoma eye drops, and the other group (60 eyes) used TA. Statistically significant reductions in IOP and CCT were observed in both groups. The mean reduction in IOP over a three year period was -2.18 ¡¾ 2.83 mmHg in the LA group and -2.08 ¡¾ 2.40 mmHg in the TA group (paired t-test, p < 0.001, for both). In terms of CCT, the mean reduction was -20.24 ¡¾ 22.92 ¥ìm in the LA group and -32.90 ¡¾ 32.04 ¥ìm in the TA group (paired t-test, p < 0.001, for both) for three years. The decrease in CCT was not significantly different between the two groups (p = 0.061). There was no significant difference in the IOP reduction between the two drugs nor was there a significant correlation between the IOP and the CCT.

Conclusions: This study indicated that 0.005% LA and 0.0015% TA had similar effects on the reduction of IOP and CCT for three years without damaging the corneal endothelium.

Å°¿öµå

Corneal thickness; Glaucoma; Intraocular pressure; Latanoprost; Tafluprost

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS